Steroid Treatment for Kidney Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
NephrosisFocal Lipoid Glomerulosclerosis
Interventions
DRUG

Oral dexamethasone

"Stage I: Dexamethasone 25 mg/m2, 2 doses every 2 weeks over 48 weeks or dexamethasone 25 mg/m2, 4 doses every 4 weeks over 48 weeks.~Stage II: 1.) Dexamethasone 50 mg/m2, 2 daily doses every 12 weeks, followed by 25 mg/m2, 2 daily doses every 2 weeks over 36 weeks, or 2.) Dexamethasone 50 mg/m2, 4 daily doses every 4 weeks over 12 weeks, followed by 25 mg/m2, 4 daily doses every 4 weeks over 36 weeks.~over 36 weeks."

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00065611 - Steroid Treatment for Kidney Disease | Biotech Hunter | Biotech Hunter